HTRA2 and endometrial cancer: Narkiewicz and colleagues (47) studied HtrA1, HtrA2 and HtrA3 mRNA and protein by two semi-quantitative techniques, RT-PCR (mRNA) and WB (protein), in 124 women; 88 with endometrial cancer and 36 with normal endometrium.